PROTEXIA Trademark

Trademark Overview

On Wednesday, February 19, 2003, a trademark application was filed for PROTEXIA with the United States Patent and Trademark Office. The USPTO has given the PROTEXIA trademark a serial number of 76491202. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 1, 2016. This trademark is owned by Nexia Biotechnologies Inc.. The PROTEXIA trademark is filed in the Chemical Products category with the following description:

Recombinant proteins in the form of biomaterials for use in the manufacture of pharmaceuticals for the prevention, treatment and detection of toxic effects of nerve agents and other chemicals
protexia

General Information

Serial Number76491202
Word MarkPROTEXIA
Filing DateWednesday, February 19, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 1, 2016
Registration Number2990033
Registration DateTuesday, August 30, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 2, 2004

Trademark Statements

Goods and ServicesRecombinant proteins in the form of biomaterials for use in the manufacture of pharmaceuticals for the prevention, treatment and detection of toxic effects of nerve agents and other chemicals

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 1, 2016
Primary Code001
First Use Anywhere DateMonday, December 8, 2003
First Use In Commerce DateMonday, December 8, 2003

Trademark Owner History

Party NamePHARMATHENE CANADA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressVAUDREUIL-DORION J7V 8P5
Party NamePHARMATHENE CANADA, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressVAUDREUIL-DORION J7V 8P5
Party NameNexia Biotechnologies Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVaudreuil-Dorion, Quebec J7V 8P5
CA
Party NameNexia Biotechnologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVaudreuil-Dorion, Quebec J7V 8P5
CA

Trademark Events

Event DateEvent Description
Friday, April 1, 2016CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, July 21, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, July 21, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, July 21, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 9, 2011TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 10, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 10, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 21, 2011REVIEW OF CORRESPONDENCE COMPLETE
Tuesday, January 18, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 14, 2010PAPER RECEIVED
Friday, June 13, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 13, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 30, 2005REGISTERED-PRINCIPAL REGISTER
Thursday, July 14, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, July 14, 2005ASSIGNED TO LIE
Friday, July 8, 2005ASSIGNED TO LIE
Friday, July 1, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 21, 2005STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 14, 2005USE AMENDMENT FILED
Tuesday, June 14, 2005TEAS STATEMENT OF USE RECEIVED
Monday, June 13, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 13, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 25, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 2, 2004PUBLISHED FOR OPPOSITION
Wednesday, October 13, 2004NOTICE OF PUBLICATION
Wednesday, September 8, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 20, 2004ASSIGNED TO LIE
Tuesday, August 10, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 4, 2004AMENDMENT FROM APPLICANT ENTERED
Wednesday, July 14, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 14, 2004PAPER RECEIVED
Tuesday, March 9, 2004FINAL REFUSAL MAILED
Wednesday, February 11, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 11, 2004PAPER RECEIVED
Friday, August 8, 2003NON-FINAL ACTION MAILED
Thursday, August 7, 2003ASSIGNED TO EXAMINER

Related Keywords

protexia effects toxic nerve agents chemicals other detection treatment form proteins